| Serial Number | 97237382 |
| Word Mark | PROVIROMICS |
| Filing Date | Tuesday, January 25, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Wednesday, March 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 24, 2023 |
| Goods and Services | Vaccines; Biological preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Medical preparations for the treatment of diseases, disorders and illnesses, namely, infectious diseases, cancer, osteporosis, kidney diseases, liver diseases, viral infections, and for use in oncology and retroviruses; Pharmaceutical preparations for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic pharmaceuticals for the treatment of diseases, disorders and illnesses, namely, cancer, osteoporosis, kidney diseases, liver diseases, viral infections, infectious diseases, and retroviruses; Therapeutic vaccines |
| Goods and Services | Scientific and technological services, namely, testing in the field of viruses used for clinical and treatment purposes in the nature of virus testing for medical diagnostic or treatment purposes |
| Goods and Services | Bacteriological research and analysis; Bacteriological research and testing; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials involving viruses used for clinical and treatment purposes; Consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific and technological services, namely, design, engineering, research, development and testing in the field of immunopharmaceuticals and vaccines involving viruses used for clinical and treatment purposes |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 31, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 31, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 14, 2022 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Retroviral Therapeutics LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lincoln, MA 01773 |
| Party Name | Retroviral Therapeutics LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lincoln, MA 01773 |
| Event Date | Event Description |
| Thursday, March 21, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, March 20, 2024 | SOU EXTENSION 2 GRANTED |
| Wednesday, March 20, 2024 | SOU EXTENSION 2 FILED |
| Wednesday, March 20, 2024 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 21, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, September 19, 2023 | SOU EXTENSION 1 GRANTED |
| Tuesday, September 19, 2023 | SOU EXTENSION 1 FILED |
| Tuesday, September 19, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, March 21, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, January 24, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, January 24, 2023 | PUBLISHED FOR OPPOSITION |
| Friday, January 20, 2023 | ASSIGNED TO EXAMINER |
| Wednesday, January 4, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Friday, December 16, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 16, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Friday, December 16, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, December 16, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Friday, December 16, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, December 14, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 14, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, December 14, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 14, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 14, 2022 | NON-FINAL ACTION E-MAILED |
| Tuesday, June 14, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, May 24, 2022 | ASSIGNED TO EXAMINER |
| Monday, January 31, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 28, 2022 | NEW APPLICATION ENTERED |